Lifeboat Foundation

Can cannabidiol (CBD) be used to counter insecticide resistance, specifically for mosquitoes? This is what a recent study published in Insects hopes to address as a team of researchers investigated how hemp leaf extract could be used to kill mosquito larvae that is responsible for yellow fever. This study holds the potential to help researchers better understand how cannabis can be used to fight insecticide resistance and mitigate yellow fever around the world.

“Mosquitoes are one of the deadliest animals in the world, mainly because as adults they serve as vectors of disease,” said Erick Martinez Rodriguez, who is a graduate student in entomology at The Ohio State University and lead author of the study. “It’s very important to be able to control these pests at an early stage, when they are at the most vulnerable.”

This study builds off a 2018 study from The Ohio State University that a Madagascar-native plant successfully worked as a mosquito insecticide. For this recent study, the researchers created CBD from ground-up hemp extract and fed this CBD to mosquito larvae with two strains of yellow fever. In the end, the researchers found both strains were effectively killed by the CBD, along with this occurring with very small amounts of CBD.

A magnetic nanoparticle (MNP)-based platform is introduced for the spatially controlled viral transduction in retina explants and whole eyes. The platform uses magnetic fields to guide adeno-associat…

NEW YORK — In a groundbreaking development, scientists have created a revolutionary method to track the spread of cancer throughout the body, potentially paving the way for more effective treatments against this devastating disease. The new technology, developed by researchers at Cold Spring Harbor Laboratory and Weill Cornell Medicine in New York, uses genetic “barcodes” to monitor the movement of individual cancer cells, providing unprecedented insights into the process of metastasis.

In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the development of the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) systems. In 2020, the Nobel Prize in Chemistry was awarded to the scientists for the discovery of CRISPR–Cas9 system, a revolutionary genome editing technology that advanced DNA therapeutics. Subsequently, the CRISPR–Cas13 system has emerged as a potential tool to identify and rectify errors in RNA sequences. CRISPR–Cas13 is a novel technology is specifically engineered for virus detection and RNA-targeted therapeutics. The CRISPR RNA (CrRNA) targets specific and non-specific RNA sequences, and Cas13 is an effector protein that undergoes conformational changes and cleaves the target RNA. This RNA-targeting system holds tremendous promise for therapeutics and presents a revolutionary tool in the landscape of molecular biology.

Now, in a recently published BioDesign Research study, a team of researchers led by Professor Yuan Yao from ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, China has elucidated the latest research trends of CRISPR–Cas13 in RNA-targeted therapies. Talking about this paper, which was published online on 6 September 2024, in Volume 6 of the journal, Prof. Yao says, “By focusing on RNA-;the intermediary between DNA and proteins-;CRISPR-Cas13 allows scientists to temporarily manipulate gene expression without inducing permanent changes to the genome. This flexibility makes it a safer option in scenarios where genome stability is critical.”

RNA plays a central role in carrying genetic information from DNA to protein-synthesizing machinery, and also regulates gene expression and participates in numerous cellular processes. Defects in RNA splicing or mutations can lead to a wide variety of diseases, ranging from metabolic disorders to cancer. A point mutation occurs when a single nucleotide is erroneously inserted, deleted, or changed. CRISPR–Cas13 plays a role in identifying and correcting these mutations by employing REPAIR (RNA editing for programmable A-to-I replacement) and RESCUE (RNA editing for specific C-to-U exchange) mechanisms. Explaining the applications of Cas13-based gene editors, Prof. Yao adds, “The mxABE editor, for example, can be used to correct a nonsense mutation linked with Duchenne muscular dystrophy that can be corrected with mxABE. This approach has proved high editing efficiency, restoring dystrophin expression to levels more than 50% of those of the wild type.”

There’s a bar in Baltimore, Maryland, that very few people get to enter.

From alcoholism to Parkinson’s, scientists are studying the mechanisms behind the broad clinical potential of weight-loss drugs.

Augmented reality (AR) takes digital images and superimposes them onto real-world views. But AR is more than a new way to play video games; it could transform surgery and self-driving cars. To make the technology easier to integrate into common personal devices, researchers report in ACS Photonics how to combine two optical technologies into a single, high-resolution AR display. In an eyeglasses prototype, the researchers enhanced image quality with a computer algorithm that removed distortions.

An epidemiologist makes the case that a rush of research to stop a swine flu outbreak led to an accidental lab release of an extinct virus. Preparing for one pandemic triggered a different one.

CHICAGO — Surgeons at Northwestern Medicine successfully completed a double-lung transplant on a Minnesota woman who was battling cancer. In 2017, at just 34 years old, Amanda “Mandy” Wilk initially suspected she had food poisoning. However, her lingering symptoms prompted further investigation, ultimately leading to her diagnosis of stage 4 colorectal cancer.

Hi folks, I’d like to invite you to a webinar I will be giving on my research, hosted by the Foresight Institute! It takes place this Friday at 12:00pm CST. You can sign up on the linked page. The donation is optional, so if you don’t want to donate, you can just put $0.00. I hope to see you there!

Biotech and Health Extension sponsored by 100 Plus Capital

Viruses inside vaults: a powerful new gene therapy delivery system

Continue reading “Logan Collins” »